BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao Y, Xu D, Li H, Xu J, Pan Y, Liao X, Qian J, Hu Y, Yu G. Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling. Front Oncol 2021;11:677678. [PMID: 34127944 DOI: 10.3389/fonc.2021.677678] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
Number Citing Articles
1 Vergani E, Beretta GL, Aloisi M, Costantino M, Corno C, Frigerio S, Tinelli S, Dugo M, Accattatis FM, Granata A, Arnaboldi L, Rodolfo M, Perego P, Gatti L. Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma. Front Cell Dev Biol 2022;10:927118. [DOI: 10.3389/fcell.2022.927118] [Reference Citation Analysis]
2 Pan Y, Liao X, Yang L, Zhang C, Wang J, Zheng P, Yu G, Song H. Extract of Marsdenia tenacissima (Roxb.) Moon [Apocynaceae] Suppresses Hepatocellular Carcinoma by Inhibiting Angiogenesis. Front Pharmacol 2022;13:900128. [DOI: 10.3389/fphar.2022.900128] [Reference Citation Analysis]
3 Zhou Z, Liang S, Zhou Z, Liu J, Meng X, Zou F, Yu C, Cai S. Avasimibe Alleviates Disruption of the Airway Epithelial Barrier by Suppressing the Wnt/β-Catenin Signaling Pathway. Front Pharmacol 2022;13:795934. [DOI: 10.3389/fphar.2022.795934] [Reference Citation Analysis]
4 Xiong K, Wang G, Peng T, Zhou F, Chen S, Liu W, Ju L, Xiao Y, Qian K, Wang X. The cholesterol esterification inhibitor avasimibe suppresses tumour proliferation and metastasis via the E2F-1 signalling pathway in prostate cancer. Cancer Cell Int 2021;21:461. [PMID: 34461908 DOI: 10.1186/s12935-021-02175-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]